Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Hims & Hers Health Inc
(NY:
HIMS
)
16.52
-0.04 (-0.27%)
Streaming Delayed Price
Updated: 3:56 PM EDT, Aug 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Hims & Hers Health Inc
< Previous
1
2
3
4
5
Next >
Top 3 Stocks to Watch: Options Traders Bet on Big Gains
August 13, 2024
Three stocks have stood out for call option traders to bet on in the coming months as a view for a recovery rally after an S&P 500 sell-off last week
Via
MarketBeat
Topics
Stocks
Exposures
US Equities
MarketBeat Week in Review – 8/5 - 8/9
August 10, 2024
Stocks were looking for direction to end the week, but next week may bring more volatility with the latest reading on inflation and the start of retail earnings
Via
MarketBeat
Topics
Economy
Exposures
Economy
Interest Rates
Hims & Hers Reports Stellar Quarter: Stock Set for a Rally
August 06, 2024
Hims & Hers stock is showing the market why its fair value is double-digits above where it trades today, with Wall Street analysts to agree
Via
MarketBeat
Topics
Bonds
ETFs
Exposures
Debt Markets
Hims & Hers Health Inc. (NYSE: HIMS) Near the Top of Equities by Percentage Gain on 2/27
February 27, 2024
Via
Investor Brand Network
Hims & Hers Health, Inc. Reports Second Quarter 2024 Financial Results
August 05, 2024
From
Hims & Hers
Via
Business Wire
Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
August 03, 2024
Hims & Hers stock is looking like a worthy dip to watch in the coming months, especially as its decline had nothing to do with company operations
Via
MarketBeat
Can the New CEO Revive This Struggling Telehealth Stock?
July 24, 2024
Virtual healthcare provider Teladoc Health Inc. (NYSE: TDOC) stock is trading down 57.8% year-to-date (YTD). The collapse occurred after reporting Q4 2023
Via
MarketBeat
Topics
Earnings
Exposures
Financial
Pharmaceutical Industry Chief Kåre Schultz Joins Hims & Hers Board
July 22, 2024
From
Hims & Hers
Via
Business Wire
Is This Telehealth Stock a Buy After the Recent Pullback?
July 19, 2024
Hims & Hers Health leverages telehealth's accessibility to disrupt traditional healthcare and deliver personalized wellness solutions.
Via
MarketBeat
Hims & Hers to Announce Second Quarter 2024 Financial Results on August 5, 2024
July 15, 2024
From
Hims & Hers
Via
Business Wire
Eli Lilly's Stock Surge Driven by GLP-1 Demand
June 20, 2024
Shares of Eli Lilly stock are about to hit a new all-time high, sponsored by the pending approval of new weight loss drugs
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
3 Sector Stars Lead Growth: Foot Locker, Shake Shack, Hims & Hers
June 10, 2024
These three stocks are looking to get a chunk of the total added jobs in the economy, meaning that analyst double-digit upside and growth projections are real
Via
MarketBeat
Topics
Economy
Exposures
Economy
MarketBeat Week in Review – 6/3 - 6/7
June 08, 2024
Equity markets shrugged off a much hotter-than-expected jobs report, but there could be more volatility after the next readings on inflation come out next week
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Hims & Hers Health Soars on Generic GLP-1 Rollout Plans
June 03, 2024
Him & Hers Health Inc. (NYSE: HIMS) provides a direct-to-consumer (DTC) health and wellness platform. The company was best known for prescribing treatments
Via
MarketBeat
Call Option Volumes Spiked For These 3 Stocks
May 30, 2024
Option traders decided to plow into call contracts for these three stocks, investors can see the specific fundamental reasons behind this decision
Via
MarketBeat
LifeMD Can Surge on Its GLP-1 Offerings
May 28, 2024
LifeMD is a leading telehealth provider that investors should take note of; the company is entering the GLP-1 market, and its stock could soar as a result
Via
MarketBeat
Hims & Hers Announces Access to GLP-1 Injections, Passing Cost Savings Onto Customers
May 20, 2024
From
Hims & Hers
Via
Business Wire
Hims & Hers Welcomes Anja Manuel, Foreign Policy Expert, Domestic Regulations Advisor, and Former Diplomat to its Board of Directors
May 16, 2024
From
Hims & Hers
Via
Business Wire
3 Stocks That Suddenly Drew in Options Traders
May 13, 2024
Three discounted stocks caught the attention of call option buyers last week, and they have Wall Street analysts to back them through double-digit upside.
Via
MarketBeat
Hims & Hers Health Stock Could Become a Wealth Compounder
May 07, 2024
Hims & Hers stock could give investors the best of both stability and double-digit upside through EPS projections and price targets, especially after 1Q24
Via
MarketBeat
Topics
Economy
Exposures
Economy
Hims & Hers Health, Inc. Reports First Quarter 2024 Financial Results
May 06, 2024
From
Hims & Hers Health, Inc.
Via
Business Wire
Hims & Hers to Announce First Quarter 2024 Financial Results on May 6, 2024
April 15, 2024
From
Hims & Hers Health, Inc.
Via
Business Wire
Hims & Hers Appoints Christopher Payne, Seasoned Tech Industry Executive, as Newest Board Member
April 04, 2024
From
Hims & Hers Health, Inc.
Via
Business Wire
3 Stocks With Unusual Call Option Activity
March 26, 2024
Three stocks reported rising call option buying activity could see even higher prices soon. Analysts see the writing on the wall, and traders stampeded in
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
LifeMD Shares Come Back to Life on GLP-1 Business Growth
March 19, 2024
LifeMD stock is surging as the company is riding the GLP-1 trend to double-digit revenue growth and projections for 67% earnings growth in 2024
Via
MarketBeat
Can WeightWatchers Regain its Mojo after Oprah Steps Down?
March 13, 2024
WW International Inc. (NASDAQ: WW) (WeightWatchers) has had a disastrous 2024, with its shares collapsing 66.7% year-to-date (YTD).
Via
MarketBeat
Hims & Hers to Participate in Canaccord Genuity's Virtual eCommerce Sustainable Advantage Forum on March 14, 2024
March 11, 2024
From
Hims & Hers Health, Inc.
Via
Business Wire
Hims & Hers Stock Rises On Stimulating Earnings Growth
March 05, 2024
Telehealth platform Hims & Hers has turned the corner into GAAP profitability and is expanding its product portfolio to increase its addressable audience
Via
MarketBeat
bluebird bio stock is ripe for a 400% institutional short squeeze
February 27, 2024
Bluebird Bio stock could be on the verge of a 400% pop on earnings, management has set the writing on the wall for institutional buying to trickle in
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
February 26, 2024
From
Hims & Hers Health, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.